Autism dietary supplement OSR#1 sales halted, FDA calls unapproved
Trine Tsouderos
Pharmacies are halting sales of OSR#1, a compound marketed as a dietary supplement to parents of children with autism, six weeks after the U.S. Food and Drug Administration called the product an unapproved new drug. Several pharmacists told the Chicago Tribune they received an e-mail last week from Boyd Haley, president of the company that makes the product, informing them that OSR#1 would not be available after Thursday. One online pharmacy, Forrest Health, posted this message: "CTI Science has volun ..
